Annual Working Capital
$945.10 K
+$12.93 M+107.89%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual working capital is $945.10 thousand, with the most recent change of +$12.93 million (+107.89%) on December 1, 2023.
- During the last 3 years, CYTO annual working capital has fallen by -$8.88 million (-90.38%).
- CYTO annual working capital is now -98.25% below its all-time high of $53.91 million, reached on December 31, 2014.
Performance
CYTO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$703.90 K
-$1.65 M-174.48%
June 1, 2024
Summary
- As of February 8, 2025, CYTO quarterly working capital is -$703.90 thousand, with the most recent change of -$1.65 million (-174.48%) on June 1, 2024.
- Over the past year, CYTO quarterly working capital has increased by +$3.34 million (+82.60%).
- CYTO quarterly working capital is now -101.17% below its all-time high of $60.12 million, reached on September 30, 2014.
Performance
CYTO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CYTO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +107.9% | +82.6% |
| 3 y3 years | -90.4% | +94.1% |
| 5 y5 years | -38.1% | +94.1% |
CYTO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.9% | -174.5% | +94.1% |
| 5 y | 5-year | -90.4% | +107.9% | -107.2% | +94.1% |
| alltime | all time | -98.3% | +107.9% | -101.2% | +94.1% |
Altamira Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -$703.90 K(-174.5%) |
| Dec 2023 | $945.10 K(-107.9%) | $945.10 K(-123.4%) |
| Jun 2023 | - | -$4.05 M(-66.2%) |
| Dec 2022 | -$11.98 M(+1324.6%) | -$11.98 M(+45.5%) |
| Jun 2022 | - | -$8.24 M(+879.4%) |
| Dec 2021 | -$841.20 K(-108.6%) | -$841.20 K(-112.7%) |
| Jun 2021 | - | $6.60 M(-32.9%) |
| Dec 2020 | $9.83 M(+9838.4%) | $9.83 M(-560.1%) |
| Jun 2020 | - | -$2.14 M(-2260.3%) |
| Dec 2019 | $98.90 K(-93.5%) | $98.90 K(-97.9%) |
| Jun 2019 | - | $4.64 M(+204.3%) |
| Dec 2018 | $1.53 M(-72.7%) | $1.53 M(-337.8%) |
| Sep 2018 | - | -$641.60 K(-84.7%) |
| Jun 2018 | - | -$4.19 M(-200.2%) |
| Mar 2018 | - | $4.18 M(-25.1%) |
| Dec 2017 | $5.59 M | $5.59 M(-43.6%) |
| Sep 2017 | - | $9.91 M(-42.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $17.30 M(-29.6%) |
| Mar 2017 | - | $24.58 M(+1.3%) |
| Dec 2016 | $24.31 M(-46.5%) | $24.28 M(-24.2%) |
| Sep 2016 | - | $32.05 M(+12.3%) |
| Jun 2016 | - | $28.54 M(-24.3%) |
| Mar 2016 | - | $37.69 M(-17.0%) |
| Dec 2015 | $45.43 M(-15.7%) | $45.43 M(-12.3%) |
| Sep 2015 | - | $51.79 M(-13.4%) |
| Jun 2015 | - | $59.83 M(+27.7%) |
| Mar 2015 | - | $46.86 M(-13.1%) |
| Dec 2014 | $53.91 M(+497.2%) | $53.91 M(-10.3%) |
| Sep 2014 | - | $60.12 M(+393.0%) |
| Jun 2014 | - | $12.20 M(-31.6%) |
| Mar 2014 | - | $17.82 M(+97.4%) |
| Dec 2013 | $9.03 M(-1804.8%) | $9.03 M |
| Dec 2012 | -$529.50 K(-270.8%) | - |
| Dec 2011 | $310.00 K | - |
FAQ
- What is Altamira Therapeutics annual working capital?
- What is the all time high annual working capital for Altamira Therapeutics?
- What is Altamira Therapeutics annual working capital year-on-year change?
- What is Altamira Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly working capital year-on-year change?
What is Altamira Therapeutics annual working capital?
The current annual working capital of CYTO is $945.10 K
What is the all time high annual working capital for Altamira Therapeutics?
Altamira Therapeutics all-time high annual working capital is $53.91 M
What is Altamira Therapeutics annual working capital year-on-year change?
Over the past year, CYTO annual working capital has changed by +$12.93 M (+107.89%)
What is Altamira Therapeutics quarterly working capital?
The current quarterly working capital of CYTO is -$703.90 K
What is the all time high quarterly working capital for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly working capital is $60.12 M
What is Altamira Therapeutics quarterly working capital year-on-year change?
Over the past year, CYTO quarterly working capital has changed by +$3.34 M (+82.60%)